Cargando…

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering

In cellular immunotherapies, natural killer (NK) cells often demonstrate potent antitumor effects in high-risk cancer patients. But Good Manufacturing Practice (GMP)-compliant manufacturing of clinical-grade NK cells in high numbers for patient treatment is still a challenge. Therefore, new protocol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oberschmidt, Olaf, Morgan, Michael, Huppert, Volker, Kessler, Joerg, Gardlowski, Tanja, Matthies, Nadine, Aleksandrova, Krasimira, Arseniev, Lubomir, Schambach, Axel, Koehl, Ulrike, Kloess, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590729/ https://www.ncbi.nlm.nih.gov/pubmed/30997855 http://dx.doi.org/10.1089/hgtb.2019.039

Ejemplares similares

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2017)

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2018)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017)

Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells
por: Tischer, Sabine, et al.
Publicado: (2014)

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
por: Müller, Stephan, et al.
Publicado: (2020)

Automated Enrichment, Transduction, and Expansion of Clinical-Scale CD62L(+) T Cells for Manufacturing of Gene Therapy Medicinal Products
por: Priesner, Christoph, et al.
Publicado: (2016)

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
por: Koehl, Ulrike, et al.
Publicado: (2013)

Advantages and applications of CAR-expressing natural killer cells
por: Glienke, Wolfgang, et al.
Publicado: (2015)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
por: Moiani, Arianna, et al.
Publicado: (2014)

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids
por: Klöss, Stephan, et al.
Publicado: (2015)

Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy
por: Rudek, Loreen Sophie, et al.
Publicado: (2021)

Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application
por: Schott, Juliane W., et al.
Publicado: (2019)

Alpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy
por: Suerth, Julia D., et al.
Publicado: (2014)

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18
por: Glienke, Wolfgang, et al.
Publicado: (2022)

Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
por: Giannattasio, Ariane, et al.
Publicado: (2015)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

Editorial: Translating NK cell scientific research to clinical product manufacturing
por: Ullrich, Evelyn, et al.
Publicado: (2023)

Interplay between the alpharetroviral Gag protein and SR proteins SF2 and SC35 in the nucleus
por: Rice, Breanna L., et al.
Publicado: (2015)

Extracorporeal immune cell therapy of sepsis: ex vivo results
por: Klinkmann, Gerd, et al.
Publicado: (2022)

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Nowak, Juliette, et al.
Publicado: (2023)

Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms
por: Priesner, Christoph, et al.
Publicado: (2016)

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation
por: Sundarasetty, Bala Sai, et al.
Publicado: (2015)

Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution
por: Koehl, Ulrike, et al.
Publicado: (2018)

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
por: Koehl, U., et al.
Publicado: (2015)

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123
por: Morgan, Michael A., et al.
Publicado: (2021)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property
por: Delso-Vallejo, María, et al.
Publicado: (2017)

NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44
por: Klapdor, Rüdiger, et al.
Publicado: (2021)

NK cells engineered to express a GD(2)-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
por: Esser, Ruth, et al.
Publicado: (2012)

IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
por: Brehm, Claudia, et al.
Publicado: (2011)

Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL
por: Bialek-Waldmann, Julia K., et al.
Publicado: (2021)

Influence of Manufacturing Regimes on the Phase Transformation of Dental Zirconia
por: Wertz, Markus, et al.
Publicado: (2021)

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases
por: Grote, Stefan, et al.
Publicado: (2021)

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
por: Stroncek, David F., et al.
Publicado: (2017)

CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
por: Sabbah, Mohamad, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk
por: Aleksandrova, Krasimira, et al.
Publicado: (2012)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B
por: Feigl, Frederik Fabian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nis6809l7648qntl0h4rr1j6vd